Based on comprehensive gene expression profiling, breast tumors are classified into at least three major subtypes: luminal, human epidermal growth factor receptor 2+ (HER2+) and basal-like (8,9), with different risk factors for incidence, response to treatment, disease progression and preferential organ sites of metastases (10–12). The gene discussed is ERBB2; the disease is breast neoplasm.